Tasquinimod, a new cancer drug, appears to control genes associated with Parkinson's disease, a new study reports.
Children who experienced higher levels of distress and less physical contact had a lower epigenetic age than those who were picked up and held more frequently, researchers report. Lower epigenetic age, researchers note, may impede a child's ability to thrive.
Researchers believe their findings could lead to new targets for brain cancer therapies.
Researchers find genetic mutations which appear to underlie a rare syndrome which combines reproductive failure with cerebella ataxi and dementia.
A new study reports researchers have successfully directed stem cell derived neurons to regenerate lost tissue following corticospinal injury in rats.
Researchers have uncovered the molecular structure of three major complexes of glutamate receptors in the hippocampus. The findings shed new light on the mechanisms behind memory and learning in the brain.
Researchers discover a gene essential for memory extinction. The finding could lead to new treatments for PTSD.
A new brain tissue study has shown gene expression in bipolar patients treated with antipsychotic medications is similar to the expression in subjects with no history of bipolar disorder.
A groundbreaking new study that looked at brain samples from humans with Fragile X reports the window for treatment remains open well into maturity.
UCSF researchers report neural stem cells only have a very limited capacity to replenish brain tissue.
A fragment of the neuropeptide Galanin appears to play a role in anhedonia in mouse models of depression. Galanin could be a potential target for the treatment of depression.
Reprogramming skin cells from dysautonomia patients, researchers create neural crest cells which mirror aspects of the cells that cause the disease.
